From January 1, 2024 to March 31, 2024, the company has repurchased 4,000,000 shares, representing 2.1% for CNY 35.97 million. With this, the company has completed the repurchase of 4,000,000 shares, representing 2.1% for CNY 35.97 million under the buyback announced on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 CNY | +1.02% |
|
-3.30% | -33.45% |
27/05 | Tibet Aim Pharm. Inc. Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024 | CI |
20/05 | Tibet AIM Pharm. Inc. Approves Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-33.45% | 203M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.